Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

(Sharecast News) - European regulators have expanded the usage of GSK's Jemperli drug for endometrial ... (Alliance News) - Pfizer Inc sold 700 million shares in Haleon PLC, as planned, more ...

Pfizer said in October that it is considering ... Walmsley said that “it would be weird” if GSK does not look at buying the business. But GSK is only looking at the business Walmsley said ...

It wants to get ahead of competitors such as BMS, Merck, Pfizer, and in particular, its Swiss neighbours and cancer leaders Roche. The deal includes two recently approved GSK products for ...

Investors would want to prepare for rotating out of the seven - Apple (AAPL), Microsoft (MSFT), Alphabet (GOOGL), Amazon (AMZN), Nvidia (NVDA), Meta (META), and Tesla (TSLA). In exchange, they ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

A HUGE study that has been launched to find treatments for diseases by measuring how the proteins circulating in our bodies ...

Cura Health, a leading provider in Kuwait's pharmaceutical and healthcare sector, today hosted a wellness event for its ...

MHRA’s independence also questioned during Commons debate, with regulator accused of being too close to companies it ...